TERRASCENT CORP - TSNDF STOCK NEWS

TerrAscend Corp, a major North American cannabis company, has opened The Apothecarium Nottingham, its fourth retail location in Maryland and 39th dispensary nationwide. The new dispensary, located at 8241 Perry Hall Blvd, Nottingham, MD, features a convenient drive-thru and an expanded floor plan. Replacing The Apothecarium Parkville, it serves both patients and adult-use consumers. The location near I-95 and White Marsh Mall offers a wide range of high-quality cannabis products and brands. The grand opening is set for June 13th, with a ribbon-cutting ceremony and various promotions. The company is investing in Maryland's growing market and has recently doubled its cultivation facility's capacity.

TerrAscend has opened its 20th Michigan dispensary, GAGE 313, in Detroit, at 14239 8 Mile Road. This location is TerrAscend’s third in Detroit and aims to provide a top-notch customer experience with a diverse product range, including offerings from brands such as Cookies, GAGE, Kind Tree, Legend, Lemonnade, and local minority-owned brands. Executive Chairman Jason Wild emphasized the company's dedication to Michigan's market, aiming for efficiency and profitability. A grand opening celebration is scheduled for May 31 and June 1, featuring notable attendees and events.

TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, has announced their participation in key conferences this May. The executive management team, including Executive Chairman Jason Wild, CEO Ziad Ghanem, and CFO Keith Stauffer, will represent the company at the 19th Annual Needham Technology, Media, & Consumer Virtual Conference (May 14-16, 2024) and the Canaccord Genuity 8th Annual Global Cannabis Conference in New York City (May 23, 2024). Highlights include a virtual fireside chat by Wild on May 16th at 3:00 PM ET and a panel discussion on emerging US markets on May 23rd at 2:15 PM ET.

TerrAscend Corp. reported a net revenue of $80.6 million, a 16.1% increase year-over-year, with a gross profit margin of 48.0%. The company achieved positive free cash flow and EBITDA growth, showing strong financial performance. Operational highlights include debt reduction, sales growth in Pennsylvania and Michigan, and strategic acquisitions. While net loss decreased, adjusted EBITDA increased by 33%, indicating overall positive business performance.

TerrAscend Corp. launches Legend mini pre-roll packs in New Jersey, offering consumers quality cannabis flower at everyday prices. The packs will be available exclusively at Apothecarium dispensaries in New Jersey starting April 26, expanding to the rest of the state on April 29. Each pack contains eight .375g pre-rolls with unique blends of two to three strains, catering to different preferences. TerrAscend aims to meet consumer demand for smaller, affordable, and convenient cannabis products, reinforcing its commitment to innovation in the New Jersey market.

TerrAscend Corp. to host conference call to discuss first quarter 2024 financial results on May 9, 2024. Investors can access the webcast or dial-in for details.

TerrAscend Corp. reports a record Net Revenue of $317.3 million in 2023, marking a 28.0% increase year-over-year. The company also achieved a Gross Profit margin of 50.3%, showing a 930 basis-point improvement. Adjusted EBITDA from continuing operations reached $68.8 million, up by 77.1% year-over-year. TerrAscend delivered its first full year of positive Cash Flow and Free Cash Flow.

TerrAscend Corp. to discuss Q4 and full-year 2023 results in conference call on March 14, 2024.

TerrAscend Corp. celebrates Governor Shapiro's endorsement of Pennsylvania's adult-use cannabis program, proposing legalization effective July 1st, 2024, and full adult-use sales commencing January 1, 2025. This move is expected to expand TerrAscend's offerings to adult-use consumers, making Pennsylvania its largest market. TerrAscend currently operates six dispensaries and its largest cultivation and production facility in the state.